BioXcel Therapeutics (BX20.MU) Q2 2026 Earnings

11MayConfirmed
Next
-0.45
-0.12
0.21
0.55

Details

Expected EPS
-0.454877475
Actual EPS
N/A
Surprise EPS
0.45
Surprise Percent
+100%

Description

BioXcel Therapeutics (BX20.MU) will report earnings of for Q2 2026 on May 11, 2026.

0 Comments

Share your thoughts